HONG KONG – Sanofi Pasteur Ltd. is taking a stand for itself amid a controversy that has quickly become a legal battle. The Public Attorney's Office of the Philippines (PAO) is taking legal action against Sanofi over the controversy surrounding the dengue vaccine Dengvaxia. And, the Filipino government agency recently filed a lawsuit against the French pharma company to demand compensation of up to PHP4.2 million (US$81,164) for the parents of Anjielica Pestilos, a 10-year-old girl the agency claims had died as a result of receiving its dengue vaccine. Read More
PERTH, Australia – Allergan plc is acquiring Sydney-based Elastagen Pty Ltd., a private company with a tissue repair platform that complements Allergan's aesthetic and dermatology franchise.
Read More
The first high-performance plasma biomarkers for Alzheimer's disease (AD) have been validated in an international collaborative study, which was reported in the Jan. 31, 2018, edition of Nature. Read More
Wuxi Biologics, of Shanghai, said partner Tychan Pte Ltd., of Singapore, dosed the first patient with Zika antibody tyzivumab in a phase Ia trial in Singapore. Tyzivumab is directed against a specific quaternary epitope of the envelope (E) protein on the surface of the virus, limiting viral fusion to host cells and preventing viral replication. Read More
